Table 3.
The Associations of the Level of PIV with Clinicopathological Characteristics
Parameter | PIV<93.01 | PIV≥93.01 | P |
---|---|---|---|
Age | ≤55.56 | 65 | 0.295 |
>55.50 | 76 | ||
ER | Negative 26 | 30 | 0.348 |
Positive 79 | 111 | ||
PR | Negative 46 | 42 | 0.033 |
Positive 59 | 99 | ||
HER-2 | Negative 79 | 105 | 0.991 |
Positive 27 | 36 | ||
KI67 | Low 28 | 36 | 0.875 |
High 78 | 105 | ||
VI | No 81 | 94 | 0.095 |
Yes 25 | 47 | ||
Tumor size(cm) | ≤2.65 | 66 | 0.024 |
>2.41 | 75 | ||
ALN status | Negative 90 | 90 | <0.001 |
Positive 16 | 51 | ||
Histologic stage | I 3 | 6 | 0.918 |
II 58 | 75 | ||
III 42 | 57 |
Abbreviations: ALN, axillary lymph node; ER, estrogen receptor; PR, estrogen receptor; HER2, human epidermal growth factor receptor2; VI, vascular invasion.